Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. is identifying carbon nanotube complexes that improve cancer therapy. Their first focus is on carbon nanotubes complexed to siRNA for delivery into cancer cells, having the advantage of less toxicity than other delivery methods. The company’s first agent, a nanotube-siRNA directed toward kidney cancer, is in preclinical development.

D. Lynn Kirkpatrick
7000 Fannin, Suite 2115
Houston TX 77030
USA
(877) 223-8145
(713) 864-7512 fax.